MOZOBIL: payments to doctors
Payments that named MOZOBIL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $528K
- Providers
- 289
- Transactions
- 660
- Average per transaction
- $799
The per-transaction average — $799 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 289 providers the average total is $1,826, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $279,345 | 52.9% |
| Sanofi-aventis U.S. LLC | $248,263 | 47.1% |